Guideline for Prophylaxis of Recurrent Uncomplicated Urinary Tract Infections in Adults

Non‑Antibiotic Interventions (First‑Line Measures)

• Behavioral modifications – increase fluid intake, urge‑initiated voiding, post‑coital voiding, and avoidance of spermicide‑containing contraceptives are recommended to reduce recurrence risk. Strong recommendation. 1
• Vaginal estrogen therapy for postmenopausal individuals is strongly recommended to lower recurrence rates. Strong recommendation. 2
• Methenamine hippurate is strongly recommended for individuals without urinary tract structural abnormalities. Strong recommendation. 3
• Immunoactive prophylaxis (e.g., vaccines or immune‑modulating agents) is strongly recommended for all adult age groups. Strong recommendation. 2
• Cranberry products may be offered as an optional adjunct; evidence quality is low and findings are contradictory. Conditional recommendation. 4

Indication for Antibiotic Prophylaxis

• When non‑antimicrobial measures fail, continuous or post‑coital antibiotic prophylaxis is strongly recommended. Strong recommendation. 5

Antibiotic Regimens

Patients without sulfonamide allergy and with normal renal function

• Trimethoprim monotherapy 100 mg daily is preferred when sulfonamide allergy is present. Strong recommendation. 2
• Fosfomycin trometamol 3 g every 10 days is an effective continuous option. Strong recommendation. 5

Patients with sulfonamide allergy

• Cephalexin 125–250 mg daily provides an effective alternative. Strong recommendation. 5
• Fosfomycin trometamol 3 g every 10 days remains appropriate. Strong recommendation. 5

Patients with impaired renal function (eGFR < 30 mL/min)

• Avoid nitrofurantoin because it is contraindicated in this setting. Strong recommendation. 5
• Fosfomycin trometamol 3 g every 10 days is suitable. Strong recommendation. 5
• Cephalexin 125–250 mg daily can be used with dose adjustment. Strong recommendation. 5
• Trimethoprim‑sulfamethoxazole dosing should be adjusted according to renal function when used. Strong recommendation. 5

Duration, Monitoring, and Follow‑Up

• Periodic clinical assessment every 3–6 months is advised; some individuals may continue prophylaxis for years without significant adverse events. Strong recommendation. 5

Alternative Strategies

Post‑coital Prophylaxis

• Trimethoprim‑sulfamethoxazole 40/200 mg (or 80/400 mg) taken after sexual activity reduces recurrence in sexually related infections. Strong recommendation. 4
• Ciprofloxacin 125 mg taken post‑coitally is an alternative option. Strong recommendation. 4

Patient‑Initiated Short‑Term Therapy

• Adults may be instructed to start a short course of therapy at the first sign of urinary symptoms, provided they demonstrate reliable adherence. Strong recommendation. 6

Antibiotic Resistance and Safety

• Prophylactic antibiotic use increases the risk of resistant organisms in both pathogenic and commensal flora. Strong recommendation. 7
• Nitrofurantoin is associated with extremely low rates of pulmonary (≈0.001 %) and hepatic (≈0.0003 %) toxicity. Strong recommendation. 5

Imaging Recommendations

• Routine extensive imaging (e.g., cystoscopy, full abdominal ultrasound) is not indicated in women < 40 years with recurrent uncomplicated UTIs and no risk factors. Strong recommendation. 2
• Imaging should be reserved for rapid recurrence (< 2 weeks), persistent bacteriuria despite therapy, or suspicion of complicated etiology. Strong recommendation. 1

Management of Asymptomatic Bacteriuria

• Treatment of asymptomatic bacteriuria in patients with a history of recurrent UTIs increases the risk of subsequent symptomatic infection (RR ≈ 3.2). Strong recommendation. 8
• Diagnosis of recurrent UTI requires a positive urine culture and the presence of urinary symptoms. Strong recommendation. 9

Post‑Coital Antibiotic Prophylaxis for Recurrent Urinary Tract Infections

Behavioral Modifications (first‑line measures)

• Encourage post‑coital voiding within 15–30 minutes after intercourse to reduce bacterial ascent. 10
• Promote adequate daily hydration to increase urinary frequency and dilute urine. 11
• Advise avoidance of spermicide‑containing contraceptives (e.g., diaphragms with spermicide) because they disrupt protective vaginal flora and raise UTI risk. 12
• Recommend urge‑initiated voiding rather than prolonged bladder holding to minimize urinary stasis. 13

Antibiotic Prophylaxis Regimens

• First‑line: Trimethoprim‑sulfamethoxazole 40/200 mg (single‑strength tablet) taken within 2 hours after intercourse is highly effective for preventing recurrent UTIs after behavioral measures have been tried. 12
• Alternative for sulfonamide allergy: Trimethoprim 100 mg alone may be used (no specific citation required for this recommendation).

Duration and Monitoring of Prophylaxis

• Initiate prophylaxis for 6–12 months, with clinical reassessment every 3–6 months to evaluate efficacy and tolerability. 12
• Women who continue to experience recurrences after stopping prophylaxis may remain on therapy for several years without notable adverse events. 12

Comparison with Continuous Daily Prophylaxis

• Post‑coital prophylaxis provides comparable protection against sexually‑related UTIs to continuous daily prophylaxis. 12
• It is associated with fewer adverse events, such as reduced gastrointestinal symptoms and lower incidence of vaginitis, compared with daily regimens. 12
• Continuous daily prophylaxis should be reserved for patients whose infections are not clearly linked to sexual activity. 12

Antibiotic Selection and Safety Considerations

• Fluoroquinolones (including ciprofloxacin) should be avoided as first‑line agents because of FDA warnings on serious adverse effects and stewardship concerns. 14
• Choice of prophylactic antibiotic should be guided by prior urine culture results and susceptibility patterns. 13
• Rotating antibiotics every 3 months may help limit the development of antimicrobial resistance. 13
• Nitrofurantoin carries an extremely low risk of serious pulmonary (≈0.001 %) or hepatic (≈0.0003 %) toxicity. 12
• All prophylactic antibiotics increase the risk of antimicrobial resistance in both pathogenic organisms and normal flora. 12
• Common mild adverse effects include gastrointestinal upset, vaginal candidiasis, and skin rash. 12

Non‑Antibiotic Adjuncts

• Lactobacillus‑containing probiotics may be considered as an adjunctive measure. 13
• Cranberry products receive a conditional recommendation; evidence is contradictory and of low quality. 12

Special Population – Postmenopausal Women

• Vaginal estrogen therapy is strongly recommended as the first‑line intervention for postmenopausal women with sexually‑related recurrent UTIs, before initiating antibiotics. 11
• If estrogen alone is insufficient, it can be combined with post‑coital antibiotic prophylaxis. 13

Imaging Recommendations

• Routine imaging (ultrasound, CT, cystoscopy) is not indicated for women with uncomplicated recurrent UTIs who are younger than 40 years, have no risk factors for complicated infection, respond promptly to therapy, and have recurrences spaced >2 weeks apart. 11, 10, 13, 12
• Imaging is indicated when there is rapid recurrence (<2 weeks after treatment), persistent bacteriuria despite appropriate therapy, or suspicion of structural abnormality/complicated etiology. 12, 10